Each week we highlight five things affecting the life sciences industry. Here's the latest. Manufacturing takes center stage in biopharma In 2024, biopharma companies prioritized manufacturing capabilities to attract investors and ensure scalability, as reported by BioSpace. Major companies are ... READ MORE >
Life sciences
Tariff discussions in health care and life sciences industries stoke global supply chain concerns
The health care and life sciences industries could be facing significant changes under a second Trump administration. From the prospect of new tariffs to the likelihood that the BIOSECURE Act will be enacted, companies are scrambling to adjust to what could be a changed operating ... READ MORE >
5 things to know in life sciences: Week of December 9, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump's nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift ... READ MORE >
5 things to know in life sciences: Week of December 2, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the Trump administration could affect the life sciences industry The incoming Trump administration may promote increased mergers and acquisitions activity in the biopharma sector due to a less restrictive ... READ MORE >
5 things to know in life sciences: Week of November 18, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024--with early trials indicating improved patient outcomes and reduced disease ... READ MORE >
5 things to know in life sciences: Week of November 11, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Addressing clinical trials challenges in biopharma ecosystem Experts at the Outsourcing in Clinical Trials Conference in New England discussed strategies for navigating the challenging biopharma ecosystem, ... READ MORE >
5 things to know in life sciences: Week of November 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the election might affect the life sciences industry Fierce Pharma provides some initial thoughts regarding the impact of Donald Trump’s election. Issues considered include changes to the Inflation ... READ MORE >
5 things to know in life sciences: Week of October 28, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. UK Parliament considering new post-market surveillance regulations The UK government has introduced new regulations for post-market surveillance of medical devices, aiming to enhance patient safety and device ... READ MORE >
Medtech executives discuss regulatory collaboration, AI, strategic funding and more
What’s on the minds of the world’s top medtech executives? I recently attended AdvaMed’s medtech conference in Toronto to explore that question. The following includes some key takeaways from the event. Governmental agencies and medtech sector demonstrate a positive working relationship As someone who ... READ MORE >
5 things to know in life sciences: Week of October 21, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New antibody discovery software unveiled Dotmatics, a research and development software provider, is launching a platform for therapeutic antibody discovery that integrates sequence visualization, antibody ... READ MORE >